Congress Weighs Who Should Have the ‘Right To Try’

There is renewed energy around a policy that would allow seriously ill patients access to experimental therapies, but lawmakers are debating who should be given this benefit.

Sen. Ron Johnson attends a Senate Governmental Affairs subcommittee hearing on international mail and the opioid crisis Jan. 25.
AP Photo/Jacquelyn Martin
×
×

Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.

Login